Journal of Health Care Compliance
Looking Ahead: DOJ Enforcement Priorities in 2025
November – December 2024
In 2024, the Department of Justice (DOJ) continued to emerge from a pandemic lull and return to vigorous enforcement of the False Claims Act (FCA) — indeed in February, DOJ announced that it had issued a record 1,504 civil investigative demands in fiscal year 2023, and its current activity levels suggest another record-breaking year. In 2025, the healthcare industry can expect that DOJ will continue to prioritize investigating alleged fraud, waste, and abuse in the industry, with particular attention paid to private equity investment, the Anti-Kickback Statute (AKS), pandemic relief fraud, and cyber fraud.
Related Blogs
Capabilities
Suggested News & Insights
Sidley Highly Ranked in Chambers USA 2026June 4, 2026DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 4, 2026DOJ Announces Accelerated Review of FCA Qui Tams Alleging Fraud Against State-Administered Benefits ProgramsMay 28, 2026Sidley Lawyers Jaime Jones, Jennifer Saulino, and Lisa Miller to Speak at the ABA′s 2026 Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C.Wednesday, May 27, 2026 – Thursday, May 28, 2026DOJ and Texas AG Announce First Settlement in National Investigation of Gender-Affirming Care for MinorsMay 26, 2026Vice President and CMS Announce Suite of New Administrative Actions to Further Federal Anti-Fraud Health Care InitiativesMay 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
